Wanbury Ltd.

Financial

	Wanbury	Ind-Swift Lab.	Anuh Pharma
Operational Metrics
Financials
5 yr Average ROE	-30.56 %	9.6 %	15.87 %
5yr average Equity Multiplier	-3.1	2.49	1.62
5yr Average Asset Turnover Ratio	1.51	0.67	1.35
5yr Avg Net Profit Margin	7.58 %	6.7 %	7.23 %
Price to Book	14.21	0.75	2.71
P/E	19.6	3.79	19.19
5yr Avg Cash Conversion Cycle	-119.82 Days	76.78 Days	42.81 Days
Inventory Days	20.62 Days	126.74 Days	50.87 Days
Days Receivable	49.78 Days	95.44 Days	111.12 Days
Days Payable	205.91 Days	94.9 Days	117.6 Days
5yr Average Interest Coverage Ratio	2.36	3.49	48.66
5yr Avg ROCE	-51.74 %	12.63 %	21.17 %
5yr Avg Operating Profit Margin	4.22 %	19.31 %	10.21 %
5 yr average Debt to Equity	-0.61	1.22	0.02
5yr CAGR Net Profit	-2.79 %	n/a	10.73 %
5yr Average Return on Assets	11.1 %	7.66 %	9.84 %
Shareholdings
Promoter Holding	39.63 %	40.94 %	69.92 %
Share Pledged by Promoters	76.74 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.22 %	-1.06 %	-0.67 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Wanbury	Ind-Swift Lab.	Anuh Pharma
Product Wise Break-Up	Product Wise Break-Up API`s & Formulation 100.0 Pharmaceuticals 0 Bulk drug and Chemicals 0	Product Wise Break-Up Bulk drug and Chemicals 0 API`s & Formulation 0 Pharmaceutical 100.0	Product Wise Break-Up Bulk drug and Chemicals 100.0 API`s & Formulation 0 Pharmaceuticals 0
Segment Break-Up	Segment Break-Up Pharmaceuticals 100.0	-	-
Location Wise Break-Up	Location Wise Break-Up India 30.27 Rest of the World 0 Others 69.73	Location Wise Break-Up India 27.72 Rest of the World 0 Others 72.28	Location Wise Break-Up India 45.02 Rest of the World 0 Others 54.98